Editas Medicine (EDIT) Other Non-Current Assets (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Other Non-Current Assets data on file, last reported at $3.0 million in Q4 2025.

• Quarterly Other Non-Current Assets fell 43.02% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (down 43.02% YoY) and the FY2025 annual result came in at $3.0 million, down 43.02% from the prior year.
• Other Non-Current Assets was little changed at $3.0 million in Q4 2025 per EDIT's latest filing, from $3.0 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $9.5 million in Q1 2024 and bottomed at $3.0 million in Q4 2025.
• The 5-year median for Other Non-Current Assets is $6.7 million (2021), against an average of $6.2 million.
• The widest annual swing landed in 2021, when Other Non-Current Assets jumped 179.72%; it then plunged 55.75% in 2025.
• Tracing EDIT's Other Non-Current Assets over 5 years: stood at $6.8 million in 2021, then retreated by 22.87% to $5.3 million in 2022, then surged by 63.49% to $8.6 million in 2023, then plunged by 39.18% to $5.2 million in 2024, then sank by 43.02% to $3.0 million in 2025.
• Per Business Quant, the three latest EDIT Other Non-Current Assets figures stand at $3.0 million (Q4 2025), $3.0 million (Q3 2025), and $4.2 million (Q2 2025).

Peer Comparison